Skip to content

Regulatory B Cells and Chronic Immune Thrombocytopenia

The Role of Regulatory B Cells in the Chronic Immune Thrombocytopenia

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02891109
Acronym
PTIREG
Enrollment
36
Registered
2016-09-07
Start date
2015-01-31
Completion date
2015-09-30
Last updated
2016-09-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Purpura, Thrombocytopenic, Idiopathic, Regulatory B Cells

Brief summary

The chronic immune thrombopenia is an autoimmune disease caused by B cells. These cells produce anti platelets and megakaryocytes antibodies. Some B cells, named regulatory B cells, are known to control other cells. Their action in chronic immune thrombopenia is actually unknown.

Detailed description

The chronic immune thrombopenia is an autoimmune disease caused by B cells. These cells produce anti platelets and megakaryocytes antibodies. Some B cells, named regulatory B cells, are known to control other cells. Their action in chronic immune thrombopenia is actually unknown. In our cohort of chronic immune thrombopenia and controls, we realized a flow cytometry analyze of B and T cells and a co-culture to determine regulatory B cells functionality.

Interventions

From the blood: B and T cells extraction then co-culture B and T cells and characterization of lymphocytes by flow cytometry

Sponsors

University Hospital, Brest
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Purpura, Thrombocytopenic, Idiopathic, chronic phase (\>12 months) * no treatment or thrombopoietin receptor agonists

Exclusion criteria

* \< 18 years * Purpura, Thrombocytopenic, Idiopathic, acute phase * pregnancy * others causes of thrombopenia

Design outcomes

Primary

MeasureTime frameDescription
Regulatory B cells functionality1 weekinhibition of T cells proliferation with co-culture B and T cells

Secondary

MeasureTime frameDescription
Cytometry immunophenotyping of B and T cells1 weekcharacterization of B and T cells by flow cytometry

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026